Turkish women with female pattern hairloss have lower hair density, and visual counting is more effective than digital image analysis for detecting this.
2 citations
,
February 2014 in “Hair therapy & transplantation”
Alopecia Areata is an autoimmune condition causing hairloss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.
PP405 shows promise in treating severe hairloss, with 31% of users experiencing over 20% hair density increase in four weeks, faster than minoxidil and finasteride. Some users are skeptical about the results' significance and long-term efficacy.
A user who tried both topical and oral Minoxidil to treat their hairloss, but had negative side effects with finasteride. They have now switched to just taking oral Minoxidil and are noticing positive results.
Hairloss treatments discussed include Minoxidil, Finasteride, and Spironolactone. One user shares success with Finasteride, Minoxidil, and low-dose Cyproterone Acetate, but warns against long-term use of oral anti-androgens.
Peptides like TB500, KPV, GHK-CU, and BPC-157 are overhyped for hair growth with limited proven effectiveness in humans. Combining peptides with delivery methods like iontophoresis and sonophoresis shows promise, but many claims remain unproven.
The user shared a 6-month aggressive hairloss treatment progress, using oral minoxidil, finasteride/minoxidil topical, dutasteride, derma stamping, Nizoral, and daily Cialis, which notably improved regrowth. Commenters observed significant improvement, with one noting a change from a Norwood 5 to a Norwood 1 in hairloss classification.